Cidara Therapeutics
CDTX
CDTX
46 hedge funds and large institutions have $112M invested in Cidara Therapeutics in 2016 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 14 increasing their positions, 10 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
46
Holders Change
–
Holders Change %
0%
% of All Funds
1.23%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
5
Increased
14
Reduced
10
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BB
BB Biotech
Schaffhausen,
Switzerland
|
+$3.56M |
| 2 |
AIC
AWM Investment Company
New York
|
+$1.46M |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
+$512K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$352K |
| 5 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
+$254K |
Top Sellers
| 1 |
Goldman Sachs
New York
|
-$3.44M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.07M |
| 3 |
DM
Deerfield Management
New York
|
-$643K |
| 4 |
SIM
Spark Investment Management
New York
|
-$270K |
| 5 |
B
Bailard
Foster City,
California
|
-$240K |